SINCALIDE

At a glance

Key dates

1. Approval

   FDA approval date of this drug product.

   Nov 22, 2022

   3 yr 8 mo ago

2. Today

3. Patent 11110063 expires

   Listed drug product patent expiration.

   Apr 20, 2038

   in 12 yr

4. Patent 11110063 expires

   Listed drug product patent expiration.

   Apr 20, 2038

   in 12 yr

5. Patent 11110063 expires

   Listed drug product patent expiration.

   Apr 20, 2038

   in 12 yr

6. Patent 11318100 expires

   Listed drug product patent expiration.

   Apr 20, 2038

   in 12 yr

7. Patent 11318100 expires

   Listed drug product patent expiration.

   Apr 20, 2038

   in 12 yr

8. Patent 11318100 expires

   Listed drug product patent expiration.

   Apr 20, 2038

   in 12 yr

9. Patent 11318100 expires

   Listed drug product patent expiration.

   Apr 20, 2038

   in 12 yr

10. Patent 11737983 expires

    Listed drug product patent expiration.

    Apr 20, 2038

    in 12 yr

11. Patent 11737983 expires

    Listed drug product patent expiration.

    Apr 20, 2038

    in 12 yr

Pharmaceutical detail

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

• KINEVACBrand (NDA)

  NDA 017697 · BRACCO

  —

Listed patents (9)